Comparison

Copanlisib (dihydrochloride) European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 5 mg
Quantity options 100 mg 10mM/1mL 10 mg 50 mg 5 mg
Item no. HY-15346A-5mg
Targets PI3K
CASRN 1402152-13-9
eClass 6.1 30220300
eClass 9.0 32160605
Available
Alias BAY 80-6946 (dihydrochloride)
Purity 99.55
Product Description
Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is a potent, selective and ATP-competitive pan-class I PI3K inhibitor, with IC50s of 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ, respectively. Copanlisib dihydrochloride has more than 2, 000-fold selectivity against other lipid and protein kinases, except for mTOR. Copanlisib dihydrochloride has superior antitumor activity[1].
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
553.44
Clinical_Information
Launched
Manufacturers Research Area
Cancer
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)|H2O : 50 mg/mL (ultrasonic)
Manufacturers Target
Apoptosis; PI3K
Isoform
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Pathway
Apoptosis; PI3K/Akt/mTOR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close